HealthCentral.com

Primary thrombocythemia



Blood cells
Blood cells


Primary thrombocythemia

Alternative Names:

Essential thrombocythemia; Essential thrombocytosis
Treatment:

If a patient is having life-threatening complications, rapid decrease of the platelet count may be achieved through platelet pheresis, a procedure to remove platelets from the blood directly.



Long-term decrease of the platelet count using medications can reduce both bleeding and clotting complications. Most common medications include hydroxyurea, interferon-alpha, or anagrelide. For patients with a known clotting tendency, aspirin may help decrease clotting episodes.

Some patients do not need any treatment.


Expectations (prognosis):

The outcome varies with reports ranging from prolonged periods without complications in some people, to fatalities from complications related to hemorrhage and thrombosis in others.


Complications:
  • Severe hemorrhage
  • Thrombotic episodes (stroke, heart attack, or blood clots in extremities)
  • Acute leukemia or myelofibrosis can develop in some patients

Calling your health care provider:



Symptoms Checker